FDA Import Refusal AEK-0896550-0/10001/1 — Eli Lillyand Company
The FDA refused shipment AEK-0896550-0/10001/1 from Eli Lillyand Company (United States) on Aug 31, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Aug 31, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75